Skip to main content
Top
Published in: Diagnostic Pathology 1/2020

Open Access 01-12-2020 | Nephrectomy | Case Report

Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations

Authors: Hyun Jung Lee, Dong Hoon Shin, Joon Young Park, So Young Kim, Chung Su Hwang, Jung Hee Lee, Jee Yeon Kim, Mee Young Sol, Jong Kil Nam

Published in: Diagnostic Pathology | Issue 1/2020

Login to get access

Abstract

Background

The presence of histologically different neoplasms in the same organ is rare in pathologic practice. We report the first case of synchronous clear cell renal cell carcinoma (clear cell RCC) and papillary renal neoplasm with reverse polarity (PRNRP) with comprehensive immunohistochemical and molecular characterization using next-generation sequencing (NGS).

Case presentation

A 61-year-old man was incidentally found to have a left renal mass on imaging studies performed for workup of left back pain and urine color change for 1 week. A laparoscopic left radical nephrectomy was performed. Gross examination showed lobulated masses measuring 5.6 × 4.0 × 3.3 cm in the upper to mid pole and 1.1 × 1.0 × 1.0 cm in the lower pole. Microscopic findings revealed these to be two different separate masses of clear cell renal cell carcinoma and papillary renal neoplasm with reverse polarity. NGS analyses revealed KRAS gene mutation (c.35G > T/p.G12V in exon 2) in the papillary renal neoplasm with reverse polarity, with PIK3CA gene mutation restricted to the clear cell renal cell carcinoma (c.1624G > A/p.E542K in exon 10).

Conclusions

We report here an extraordinarily rare case of synchronous renal tumors of papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma. We identified simultaneous KRAS and PIK3CA mutations in two different renal masses in the same kidney for the first time. New pathologic assessment with comparative molecular analysis of mutational profiles may be helpful for tumor studies.
Literature
1.
go back to reference Siegel RL, Miller KD, Jermal A. Cancer statistics. CA Cancer J Clin. 2016;66:7–30.CrossRef Siegel RL, Miller KD, Jermal A. Cancer statistics. CA Cancer J Clin. 2016;66:7–30.CrossRef
2.
go back to reference Cohen HT, McGovern FJ. Renal cell carcinoma. N Engl J Med. 2005;353:2477–90.CrossRef Cohen HT, McGovern FJ. Renal cell carcinoma. N Engl J Med. 2005;353:2477–90.CrossRef
3.
go back to reference Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537–44.PubMed Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10:537–44.PubMed
4.
go back to reference Al-Obaidy KI, Eble JN, Cheng L, et al. Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol. 2019;43:1099–111.CrossRef Al-Obaidy KI, Eble JN, Cheng L, et al. Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study. Am J Surg Pathol. 2019;43:1099–111.CrossRef
5.
go back to reference Patel MI, Simmons R, Kattan MW, Motzer RJ, Reuter VE, Russo P. Long-term follow-up of bilateral sporadic renal tumors. Urology. 2003;61:921–5.CrossRef Patel MI, Simmons R, Kattan MW, Motzer RJ, Reuter VE, Russo P. Long-term follow-up of bilateral sporadic renal tumors. Urology. 2003;61:921–5.CrossRef
6.
go back to reference Klatte T, Wunderlich H, Patard JJ, et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 2007;100:21–5.CrossRef Klatte T, Wunderlich H, Patard JJ, et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 2007;100:21–5.CrossRef
7.
go back to reference Billings B, Hamrick LC, Bueschen AJ, Kenney PJ. Coexisting angiomyolipoma and renal cell carcinoma in a kidney of an elderly woman: case report and review of the literature. Sci World J. 2004;4:27–30.CrossRef Billings B, Hamrick LC, Bueschen AJ, Kenney PJ. Coexisting angiomyolipoma and renal cell carcinoma in a kidney of an elderly woman: case report and review of the literature. Sci World J. 2004;4:27–30.CrossRef
8.
go back to reference Alhusban M, Alhamss S, Alzumaili B, AI-Daghmin A. Ipsilateral synchronous clear and papillary renal cell carcinoma: A case report and review of the literature. Urol Case Rep. 2017;16:110–3.CrossRef Alhusban M, Alhamss S, Alzumaili B, AI-Daghmin A. Ipsilateral synchronous clear and papillary renal cell carcinoma: A case report and review of the literature. Urol Case Rep. 2017;16:110–3.CrossRef
9.
go back to reference Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology. 2004;64:462–7.CrossRef Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology. 2004;64:462–7.CrossRef
10.
go back to reference Richstone L, Scherr DS, Reuter VR, et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol. 2004;171:615–20.CrossRef Richstone L, Scherr DS, Reuter VR, et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol. 2004;171:615–20.CrossRef
11.
go back to reference Eberhard DA, Johnson BE, Amler LC, et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small cell lung cancer treated with chemotherapy alone in combination with erlotinib. J Clin Oncol. 2005;23:5900–9.CrossRef Eberhard DA, Johnson BE, Amler LC, et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small cell lung cancer treated with chemotherapy alone in combination with erlotinib. J Clin Oncol. 2005;23:5900–9.CrossRef
12.
go back to reference Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:1626–34.CrossRef Amado RG, Wolf M, Peeters M, et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008;26:1626–34.CrossRef
13.
go back to reference Mohri D, Asaoka Y, Ijichi H, et al. Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. J Gastroenterol. 2012;47:203–13.CrossRef Mohri D, Asaoka Y, Ijichi H, et al. Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression. J Gastroenterol. 2012;47:203–13.CrossRef
14.
go back to reference Isharwal S, Hu W, Sarungbam J, et al. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder. J Pathol. 2019;248:260–5.PubMedPubMedCentral Isharwal S, Hu W, Sarungbam J, et al. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder. J Pathol. 2019;248:260–5.PubMedPubMedCentral
15.
go back to reference Al-Obaidy KI, Eble JN, Nassiri M, et al. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity. Mod Pathol. 2020;33:1157–64.CrossRef Al-Obaidy KI, Eble JN, Nassiri M, et al. Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity. Mod Pathol. 2020;33:1157–64.CrossRef
16.
go back to reference Kim SS, Cho YM, Kim GH, et al. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma. Mod Pathol. 2020;33:690–9.CrossRef Kim SS, Cho YM, Kim GH, et al. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma. Mod Pathol. 2020;33:690–9.CrossRef
17.
go back to reference Tong K, Zhu W, Fu H, et al. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei. Histopathology. 2020;76:1070–83.CrossRef Tong K, Zhu W, Fu H, et al. Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei. Histopathology. 2020;76:1070–83.CrossRef
18.
go back to reference Creighton CJ, Morgan M, Gunaratne PH, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43–9.CrossRef Creighton CJ, Morgan M, Gunaratne PH, et al. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43–9.CrossRef
19.
go back to reference Sato Y, Toshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear cell renal cell carcinoma. Nat Genet. 2013;45:860–7.CrossRef Sato Y, Toshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear cell renal cell carcinoma. Nat Genet. 2013;45:860–7.CrossRef
20.
go back to reference Benavides-Huerto MA, Chávez-Valencia V, Lagunas-Rangel FA. Synchronous renal neoplasm: clear cell renal cell carcinoma and papillary urothelial carcinoma in the same kidney. Urol Case Rep. 2017;11:60–2.CrossRef Benavides-Huerto MA, Chávez-Valencia V, Lagunas-Rangel FA. Synchronous renal neoplasm: clear cell renal cell carcinoma and papillary urothelial carcinoma in the same kidney. Urol Case Rep. 2017;11:60–2.CrossRef
21.
go back to reference Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasm-an experience of 405 cases. Am J Surg Pathol. 2002;26:281–91.CrossRef Amin MB, Tamboli P, Javidan J, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasm-an experience of 405 cases. Am J Surg Pathol. 2002;26:281–91.CrossRef
22.
go back to reference Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence. J Urol. 2003;170:760–3.CrossRef Blute M, Thibault GP, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence. J Urol. 2003;170:760–3.CrossRef
23.
go back to reference Beaugerie A, Audenet F, Verkarre V, et al. Pathological heterogeneity in sporadic synchronous renal tumors: is the histological concordance predictable? Uorl Oncol. 2018;36:11.e7–12.CrossRef Beaugerie A, Audenet F, Verkarre V, et al. Pathological heterogeneity in sporadic synchronous renal tumors: is the histological concordance predictable? Uorl Oncol. 2018;36:11.e7–12.CrossRef
24.
go back to reference Minervini A, Serni S, Giubilei G, et al. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radiacal nephrectomy. Eur J Surg Oncol. 2009;35:521–6.CrossRef Minervini A, Serni S, Giubilei G, et al. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radiacal nephrectomy. Eur J Surg Oncol. 2009;35:521–6.CrossRef
Metadata
Title
Unilateral synchronous papillary renal neoplasm with reverse polarity and clear cell renal cell carcinoma: a case report with KRAS and PIK3CA mutations
Authors
Hyun Jung Lee
Dong Hoon Shin
Joon Young Park
So Young Kim
Chung Su Hwang
Jung Hee Lee
Jee Yeon Kim
Mee Young Sol
Jong Kil Nam
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2020
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-020-01042-7

Other articles of this Issue 1/2020

Diagnostic Pathology 1/2020 Go to the issue